MMR Vaccine - Vial of 10 Doses: Immunity Shield Against Measles, Mumps, and Rubella
ProcurenetShort description
Offer superior protection with the MMR Vaccine – a live, attenuated virus vaccine presented as a freeze-dried powder in a 10-dose vial. Key features include:
- Composition: Each dose contains at least 1000 CCID50 of measles, mumps, and rubella viruses.
- Manufacturing: Mump and measles components often originate in chicken embryo fibroblasts, while rubella components are cultivated in human diploid cells.
- Administration: Single dose of 0.5 ml, administered percutaneously to the upper arm.
- Storage: Maintain vaccine potency with storage between 2u00b0C and 8u00b0C, or frozen at -20u00b0C.
- Manufacturer-specific strain variations:
Note: Specific strain variations depend on the manufacturer.
-
Procurenet Team Tshim Sha Tsui
Hong Kong
3 years
Description
MMR Vaccine - Vial of 10 Doses: Comprehensive Protection Against Measles, Mumps, and Rubella
Given the rising resurgence of measles, mumps, and rubella (MMR), our superior quality MMR vaccine is a key for comprehensive immunization. This vaccine, manufactured under rigorous controls, assures a broad immunity coverage against critical strains of these diseases. The vaccine is delivered in a 10-dose vial, ensuring you have enough doses to cover large groups. It maintains a yellowish-white dry cake overlook, synonymous with impeccable quality and easy identification.
Key Features & Benefits:
- Offers broad immunity coverage against infectious diseases, specifically measles, mumps, and rubella.
- Each dose contains a minimum of 1000 CCID50 of each virus, ensuring maximum protection.
- Some versions offer over 5000 CCID50 of the mumps virus for enhanced coverage.
- Permitting manufacturing flexibility with diverse viral strains like Engmonston Zagreb, Schwarz, and BiKen Cam 70 for measles; L-Zagreb, Jeryl Lynn, and Urabe for mumps; and RA-27/3 for rubella.
- Trace amounts of antibiotics are used in production, eradicating bacterial contamination risks.
- The dry cake appearance is easy to reconstitute and ensures simple identification.
Administration:
The MMR vaccine is expertly designed for percutaneous administration. Ideally, the injection should be given in the upper arm using a sterile needle and syringe. Each reconstituted dose is 0.5ml. Following reconstitution, the vaccine must be stored between 2°C and 8°C, away from sunlight, used within six hours to retain efficacy.
Immunization Schedule:
Vaccine administration is feasible from as early as 9 months, depending on the region's measles prevalence. A second dose is generally recommended in places with lower measles circulation. The second dose can be administered at any time post the first dose.
Storage & Transport:
The MMR vaccine can be stored in the freezer at -20°C or refrigerator at 2°C - 8°C. The sealed vial can be transported with the available diluent. The vaccine should be shielded from sunlight during transportation.
